CIK 0001099800
- Large accelerated filer
Edwards Lifesciences Corp
Sign in to watch- Ticker
- EW
- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364316614
- Phone
- +1 949-250-2500
- Business address
- ONE EDWARDS WAY, IRVINE, CA, 92614
- Former names
- CVG CONTROLLED INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,886,105
- in 9 filings, $7.6M under 10b5-1 plans
Net −$10,886,105. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-10 | BOBO DONALD E JR CVP,Strategy/Corp Development | Sale 10b5-1 | −2,500 | $89.22 | $223K | 33,077.69 |
| 2023-05-10 | BOBO DONALD E JR CVP,Strategy/Corp Development | Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 | −2,500 | 83,000 | ||
| 2023-05-10 | Ullem Scott B. CVP, Chief Financial Officer | Exercise or conversion 10b5-1 | +80,700 | $35.20 | $2.8M | 98,994 |
| 2023-05-10 | Ullem Scott B. CVP, Chief Financial Officer | Sale 10b5-1 | −16,581 | $89.22 | $1.5M | 82,413 |
| 2023-05-10 | Ullem Scott B. CVP, Chief Financial Officer | Sale 10b5-1 | −64,119 | $88.36 | $5.7M | 18,294 |
| 2023-05-10 | Ullem Scott B. CVP, Chief Financial Officer | Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 | −80,700 | 0 | ||
| 2023-05-10 | MUSSALLEM MICHAEL A Chairman & CEO | Exercise or conversion 10b5-1 | +29,375 | $35.20 | $1.0M | 111,099.82 |
| 2023-05-10 | MUSSALLEM MICHAEL A Chairman & CEO | Sale 10b5-1 | −5,984 | $88.94 | $532K | 105,115.82 |
| 2023-05-10 | MUSSALLEM MICHAEL A Chairman & CEO | Gift 10b5-1 | −9,500 | 95,615.82 | ||
| 2023-05-10 | MUSSALLEM MICHAEL A Chairman & CEO | Sale 10b5-1 | −13,891 | $88.29 | $1.2M | 81,724.82 |
| 2023-05-10 | MUSSALLEM MICHAEL A Chairman & CEO | Gift 10b5-1 | +9,500 | 3,616,922 | ||
| 2023-05-10 | MUSSALLEM MICHAEL A Chairman & CEO | Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 | −29,375 | 0 | ||
| 2023-05-09 | Lemercier Jean-Luc M CVP, EMEACLA and JAPAC | Exercise or conversion 10b5-1 | +6,640 | $35.20 | $234K | 178,729.78 |
| 2023-05-09 | Lemercier Jean-Luc M CVP, EMEACLA and JAPAC | Sale 10b5-1 | −6,640 | $88.68 | $589K | 172,089.78 |
| 2023-05-09 | Lemercier Jean-Luc M CVP, EMEACLA and JAPAC | Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 | −6,640 | 0 | ||
| 2023-05-09 | Szyman Catherine M. CVP, Critical Care | Exercise or conversion 10b5-1 | +75,600 | $35.20 | $2.7M | 104,130.78 |
| 2023-05-09 | Szyman Catherine M. CVP, Critical Care | Sale 10b5-1 | −75,600 | $88.94 | $6.7M | 28,530.78 |
| 2023-05-09 | Szyman Catherine M. CVP, Critical Care | Exercise or conversion · Employee Stock Option (Right to Acquire) 10b5-1 | −75,600 | 0 | ||
| 2023-05-08 | Zovighian Bernard J President | Shares withheld for taxes | −1,433 | $88.74 | $127K | 22,027.87 |
| 2023-05-08 | SELLERS ROBERT W.A. SVP, Corporate Controller | Shares withheld for taxes | −161 | $88.74 | $14K | 11,235.79 |
Page 40 of 43 · 841 trades